Pharma News

ICMR to launch task force projects on burden of rotavirus diarrhoea in India

Aiming to understand the potential health benefits of rotavirus vaccination and also to develop a national representative data on rotavirus burden and strains in India, the Indian Council of Medical Research (ICMR) will soon embark on task force projects on burden of rotavirus diarrhoea in India under the Indian Rotavirus Surveillance Network.

US FDA to review once-weekly treatment for type 2 diabetes Bydureon in October

Amylin Pharmaceuticals, Inc, Eli Lilly and Company and Alkermes, Inc announced that the US Food and Drug Administration (FDA) has classified the Bydureon (exenatide for extended-release injectable suspension) complete response as a Class 2 resubmission and assigned a new Prescription Drug User Fee Act (PDUFA) action date of October 22, 2010.

GSK gets clean chit from DCGI for running cervical cancer vaccine ads in media

The multinational drug company GlaxoSmithKline (GSK), which had run an advertisement blitzkrieg in several national newspapers in the country on cervical cancer vaccine late last year in gross violation of Drugs and Cosmetics Act, 1940 and Drugs and Magical Remedies Act 1954, has been completely absolved of any irregularities by the drug controller general of India (DCGI) Dr Surinder Singh, it is learnt.

Long-Term Use of Anabolic Steroids Associated With Reduced LV Ejection Fraction

April 29, 2010 (Boston, Massachusetts) — Long-term users of anabolic androgenic steroids have a high risk of developing cardiac dysfunction, which may be severe enough to increase the risk of heart failure, a new study suggests [1].

The study, published online April 27, 2010 in Circulation: Heart Failure, was conducted by a group led by Dr Aaron Baggish (Massachusetts General Hospital, Boston, MA).

PCI warns pharmacy colleges planning to launch 2nd shift for B Pharm

The Pharmacy Council of India (PCI), the statutory body governing the pharmacy education in the country, has warned against the move by some of the institutes to start a second shift for pharmacy courses. PCI said that it would not approve such courses or students taking such courses as per the Pharmacy Act, 1948.